Cavanaugh Sarah
Officer at CLDX
- Sold, on record
- $2.5M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 30, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLDXCelldex Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale CLDXUnusualNov 1, 2021 2021
Sold 7,323 shares at $43.26 ($317k)
Cavanaugh Sarah, SVP of Corp Affairs & Admin.
Sold 94.7% of holdings ($334k position)408 shares leftFirst sale on recordFiling
- 2 Form 4 sale CLDXUnusualDec 8, 2021 +37 days
Sold 7,323 shares at $40.00 ($293k)
Cavanaugh Sarah, SVP of Corp Affairs & Admin.
Sold 94.7% of holdings ($309k position)408 shares leftFiling
- 3 Form 4 sale CLDXUnusualAug 18, 2022 +253 days
Sold 32,667 shares at $36.72 ($1.2M)
Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.
Sold 96.2% of holdings ($1.2M position)1,284 shares leftFiling
- 4 Form 144 notice CLDXNoticeMay 30, 2024 +651 days
Filed to sell 20,853 shares ($703k)
Cavanaugh Sarah, Officer
No 10b5-1 planFiling
- 5 Form 4 sale CLDXUnusualMay 30, 2024 same day
Sold 20,853 shares at $33.73 ($703k)
Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.
No 10b5-1 planSold 91.8% of holdings ($766k position)1,860 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Jun 3, 2024 | CLDX | SVP OF CORP AFFAIRS & ADMIN. | Form 4 sale | 20,853 | $703k | 91.8% | Unusual | SEC |
| May 30, 2024 | May 30, 2024 | CLDX | Officer | Form 144 notice | 20,853 | $703k | Notice | SEC | |
| Aug 18, 2022 | Aug 19, 2022 | CLDX | SVP OF CORP AFFAIRS & ADMIN. | Form 4 sale | 32,667 | $1.2M | 96.2% | Unusual | SEC |
| Dec 8, 2021 | Dec 10, 2021 | CLDX | SVP of Corp Affairs & Admin. | Form 4 sale | 7,323 | $293k | 94.7% | Unusual | SEC |
| Nov 1, 2021 | Nov 3, 2021 | CLDX | SVP of Corp Affairs & Admin. | Form 4 sale | 7,323 | $317k | 94.7% | Unusual | SEC |